Beautiful Virgin Islands

Tuesday, Jun 24, 2025

STUDY: AstraZeneca booster dose significantly neutralises Omicron

STUDY: AstraZeneca booster dose significantly neutralises Omicron

British pharmaceutical giant AstraZeneca has revealed that a third, or ‘booster’ dose of its COVID-19 vaccine significantly lifted antibody levels against the Omicron variant.

This is based on a recent laboratory study whose findings suggest that AstraZeneca’s vaccine and its preventative monoclonal antibody treatment, Evusheld, “retains neutralisation activity” against Omicron.

“The third dose booster vaccination neutralised the Omicron variant to levels that were broadly similar to those observed… after the second dose against the Delta variant,” AstraZeneca said in a statement.

According to the statement, the levels at which antibodies became neutralised from the booster jab were also higher in individuals who had previously been infected and recovered naturally.

Meanwhile, the study was conducted by investigators from the University of Oxford, which is the academic institution that helped AstraZeneca develop the vaccine last year.

Researchers also analysed blood samples taken from individuals infected with COVID-19 as well as those vaccinated with a booster and those who had reported the a previous COVID infection.

“It is very encouraging to see that current vaccines have the potential to protect against Omicron following a third dose booster. These results support the use of third dose boosters as part of national vaccine strategies, especially to limit the spread of variants of concern, including Omicron,” said University of Oxford professor John Bell, one of the researchers.

Pfizer to become the vaccine of choice for BVI


While AstraZeneca has revealed this finding, the Ministry of Health here in the BVI that announced Pfizer will become the vaccine of choice in the territory as it expects the supply ability of AstraZeneca to dwindle in the new year.

The Acting Chief Medical Officer (CMO) Dr Ronald Georges said Oxford University in the UK carried out a large trial to determine which vaccines would be most effective as boosters overall and the results showed mRNA vaccines such as Pfizer would be best.

Dr Georges also announced that persons who have completed their primary vaccination with the two-dose regimen like AstraZeneca can receive the Pfizer booster three months after completion of their last dose.

Earlier this month, the ministry received 4,680 doses of the Pfizer vaccine from the United Kingdom and more are expected to become available in January.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Airlines Evaluate Flight Cancellations Amid Escalating US-Iran Tensions
Starmer Invites Innovators to Join Government Talent Scheme
UK Economy’s Strong Opening Quarter Shows Signs of Cooling
Harrods Seeks Court Order to Secure Al Fayed Estate for Victims
BA and Singapore Airlines Cancel Dubai Flights Amid Middle East Tensions
Trump Faces Backlash from MAGA Base Over Iran Strikes
Meta Bets $14 B on Alexandr Wang to Drive AI Ambitions
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
FedEx Founder Fred Smith, ‘Heart and Soul’ of the Company, Dies at 80
Chinese Factories Shift Away from U.S. Amid Trump‑Era Tariffs
Pimco Seizes Opportunity in Japan’s Dislocated Bond Market
Labubu Doll Drives Pop Mart to Status as China’s Most Valuable Toy Maker
Global Coal Demand Defies Paris Accord Goals
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
BBC Demands Perplexity AI Immediately Stop Using Its Content
Telegram Founder: I Will Leave My Fortune to Over 100 of My Children
Political Turmoil Resurfaces in Belgium Amid Economic Concerns
Fed policymakers divided on timing of interest rate cuts
Trump signals imminent agreement with Harvard University
Inheritance tax referendum alarms Swiss billionaire community
Japan cancels bilateral security meeting amid US defence demands
AI skeptic Emily Bender warns that ‘the emperor has no clothes’
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
Plans to Sell Dutch Embassy in Bangkok Face Local Opposition
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump's $5 Million 'Trump Card' Visa Program Draws Nearly 70,000 Applicants
DGCA Finds No Major Safety Concerns in Air India's Boeing 787 Fleet
Airlines Reroute Flights Amid Expanding Middle East Conflict Zones
Elon Musk's xAI Seeks $9.3 Billion in Funding Amid AI Expansion
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Taiwan Imposes Export Ban on Chips to Huawei and SMIC
Israel has just announced plans to strike Tehran again, and in response, Trump has urged people to evacuate
Netanyahu Signals Potential Regime Change in Iran
Juncker Criticizes EU Inaction on Trump Tariffs
EU Proposes Ban on New Russian Gas Contracts
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
×